# Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rovalpituzumab-tesirine-a-dll3-targeted-antibody-drug-conjugate-in-recurrent/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Charles M. Rudin,M. Catherine Pietanza,Todd M. Bauer,Neal Ready,Daniel Morgensztern,Bonnie S. Glisson,Lauren A. Byers,Melissa L. Johnson,Howard A. Burris,Francisco Robert,Tae Hyung Han,Sheila Bheddah,Noah Theiss,Sky Watson,Deepan Mathur,Bharathi Vennapusa,Hany Zayed,Satwant Lally,Donald K. Strickland,Ramaswamy Govindan,Scott J. Dylla,Stanford L. Peng,David R. Spigel |
| Citations | 563 |
| DOI | 10.1016/s1470-2045(16)30565-4 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/5481162 |
| OpenAlex ID | https://openalex.org/W2560431464 |
| PMID | 27932068 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Charles M. Rudin](https://scholariq.org/researchers/charles-m-rudin/)
- [Lauren A. Byers](https://scholariq.org/researchers/lauren-a-byers/)
- [Hany Zayed](https://scholariq.org/researchers/hany-zayed/)
- [Bonnie S. Glisson](https://scholariq.org/researchers/bonnie-s-glisson/)
- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.